Pay in 4 interest-free payments of $6.12 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
Tumor microenvironment-responsive manganese-based nano-modulator activate the cGAS-STING pathway to enhance innate immune system response
Nature 644 , 799808 (2025)
Formulation : Each vial contains : Glutathione (as Reduced L-Glutathione)
In the Teichman et al
Figure 2: Changes in body weight from baseline to the end of treatment at week 26 associated with the treatment policy estimand, in the randomly assigned treatment groups administered either 0.3 mg of cagrilintide, 0.6 mg of cagrilintide, 1.2 mg of cagrilintide, 2.5 mg of cagrilintide, 4.5 mg of cagrilintide, 3.0 mg of liraglutide, or a placebo
Experimental design After 20 days of growth, tissue culture plantlets were divided into five groups for experimental treatment: (1) T0 (untreated), (2) Cd48 (48 h of growth following the addition of 500 mol/L of CdCl 2 to MS solution), (3) GSH48 (48 h of growth following the addition of 500 mol/L of CdCl 2 and 400 mol/L of GSH to MS solution), (4) Cd96 (96 h of growth following the addition of 500 mol/L of CdCl 2 to MS solution), and (5) GSH96 (96 h of growth following the addition of 500 mol/L of CdCl 2 and 400 mol/L of GSH to MS solution)
